Financial Ratios Forte Biosciences

Selling General & Admin Expenses, Total

R&D Expenses

Other Operating Expenses, Total

Interest Expense, Total

Interest And Investment Income

Net Interest Expenses

Other Non Operating Income (Expenses)

In Process R&D Expenses

Income Tax Expense

Net Income to Company

Net Income to Common Incl Extra Items

Net Income to Common Excl. Extra Items

Net EPS - Basic

Basic EPS - Continuing Operations

Basic Weighted Average Shares Outstanding

Net EPS - Diluted

Diluted EPS - Continuing Operations

Diluted Weighted Average Shares Outstanding

Normalized Basic EPS

Normalized Diluted EPS

EBITDA

EBITA

EBIT

EBITDAR

Effective Tax Rate - (Ratio)

Current Foreign Taxes

Total Current Taxes

Normalized Net Income

General and Administrative Expenses

Research And Development Expense From Footnotes

Net Rental Expense, Total

Stock-Based Comp., R&D Exp. (Total)

Stock-Based Comp., G&A Exp. (Total)

Total Stock-Based Compensation

Cash And Equivalents

Short Term Investments

Other Receivables

Prepaid Expenses

Other Current Assets, Total

Gross Property Plant And Equipment

Accumulated Depreciation

Deferred Charges Long-Term

Other Long-Term Assets, Total

Accounts Payable, Total

Accrued Expenses, Total

Other Current Liabilities

Other Non Current Liabilities

Preferred Stock Convertible

Total Preferred Equity

Common Stock, Total

Additional Paid In Capital

Retained Earnings

Comprehensive Income and Other

Total Common Equity

ECS Total Shares Outstanding on Filing Date

ECS Total Common Shares Outstanding

Book Value / Share

Tangible Book Value

Tangible Book Value Per Share

Total Debt

Net Debt

Debt Equivalent Oper. Leases

Account Code - Inventory Valuation

Machinery, Total

Full Time Employees

Net Income

Depreciation & Amortization - CF

Depreciation & Amortization, Total

(Gain) Loss on Sale of Investments - (CF)

Asset Writedown & Restructuring Costs

Stock-Based Compensation (CF)

Other Operating Activities, Total

Change In Accounts Payable

Change In Income Taxes

Change in Other Net Operating Assets

Capital Expenditure

Cash Acquisitions

Investment in Marketable and Equity Securities, Total

Long-Term Debt Issued, Total

Total Debt Issued

Issuance of Common Stock

Repurchase of Common Stock

Issuance of Preferred Stock

Other Financing Activities, Total

Change In Net Working Capital

Net Debt Issued / Repaid